Anh Nguyen

About Anh Nguyen

Anh Nguyen is a French-American executive in the biotech sector, best known as a founder and long-time governance leader at MedinCell. Trained as a molecular biologist and shaped by an entrepreneurial career, he began in California, where he co-founded and scaled several biotechnology companies through to NASDAQ listings. That background gave him deep experience in scientific innovation, financing growth, and building high-performing companies in technology-driven environments. He is also associated with employee-ownership concepts, which he helped bring from the United States to Europe through MedinCell. At MedinCell, Anh Nguyen played a foundational role from the company’s creation in 2003 and especially from 2013 onward, when he served as Chairman of the Supervisory Board. Under his leadership, the company established a stable governance framework, a reliable succession plan, and an organization capable of supporting international growth. He helped guide the development of MedinCell’s proprietary BEPO controlled-release technology from early research stages to a major regulatory milestone in the United States. That progress was instrumental in positioning MedinCell as a leading player in long-acting injectable therapies. His remit also included selecting therapeutic programs with meaningful social impact and building strategic partnerships with pharmaceutical companies and foundations. MedinCell has described his contribution as combining scientific ambition, governance discipline, and industrial vision to support the company’s long-term expansion. He stepped down as a member and Chairman of the Supervisory Board on February 15, 2024, upon reaching the statutory age limit. The public sources reviewed do not confirm a clearly recent operational role at Banque Populaire du Sud, although his name appears in company-related publications and documents.